Testing the drug tovorafenib in Japanese children and young adults with brain tumors
Original title: A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early test in people, so safety is still being checked.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing a drug called tovorafenib, taken by mouth once a week, in young people in Japan who have certain brain tumors.
Who this trial is for. This trial is for children, teens, and young adults in Japan who have certain brain tumors. Everyone in the study takes tovorafenib by mouth once a week.
Where it stands. This trial has not reported results. It is checking how safe the drug is and how the body takes in, moves, and gets rid of it. It is also checking how well the drug shrinks brain tumors. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: For now, this drug is being studied, not offered as regular care. A family whose situation seems to fit could ask their care team whether a study like this is worth looking into.
What it doesn't mean: This does not mean the drug works. A trial is a test, not a proven treatment. Joining a study is not a guarantee that it will help you. This is not a cure, and it is not a promise of one.
Source: ClinicalTrials.gov, July 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.